Evidence map›Paper›PMID 24610034›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2014

Growth factor signaling: implications for disease & therapeutics.

Shilpa Buch

Abstract read
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Protein Engineering for Spatiotemporally Resolved Cellular Monitoring.Annual review of analytical chemistry (Palo Alto, Calif.) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Shilpa BuchDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA, sbuch@unmc.edu.
University of Nebraska Medical Center · US

Funding

Morphine and the Neuropathogenesis of SIV in MacaquesR01DA024442 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J. · 2007 to 2011
$2.8M
Mechanism and Therapy of SHIV Encephalitis in MacaquesR01MH068212 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J. · 2003 to 2012
$2.7M
Opiate induced SIV-Neuropathogenesis: Role of miRNA-29b in the Periphery-CNS CroR01DA035203 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J. · 2013 to 2017
$2.3M
HIV Tat & Cocaine-Mediated induction of Astrogliosis: Role of ER Stress in HANDR01DA036157 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUO, MINGLEI · 2013 to 2017
$1.9M
Cocaine & HIV: Role of PDGF/PDGF-Receptor Axis in Blood Brain Barrier DisruptionR01DA027729 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., KIM, KEE JUN · 2009 to 2013
$1.8M
PDGF-BB Reverses Impaired Neurogenesis Mediated by Tat and CocaineR01DA033150 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HU, GUOKU · 2012 to 2016
$1.6M
HIV-Encephalitis and Cocaine Abuse: Mechanism of Synergy and TherapyR01DA020392 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J. · 2006 to 2010
$1.4M
PLGA/Antisense IL-10: Gene Therapy for Cocaine Abusers with HADR21DA023397 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J. · 2009 to 2010
$423k
Molecular Mechanisms & Therapy for Cocaine Abuse in HANDR21DA033614 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J. · 2011 to 2012
$403k
NIDA NIH HHS DA0277729NIDA NIH HHS DA033150NIDA NIH HHS DA033614NIDA NIH HHS DA035203NIDA NIH HHS DA036157NIDA NIH HHS R01 DA020392NIDA NIH HHS R01 DA024442NIDA NIH HHS R01 DA027729NIDA NIH HHS R01 DA033150NIDA NIH HHS R01 DA035203NIDA NIH HHS R01 DA036157NIDA NIH HHS R21 DA023397NIMH NIH HHS MH068212NIMH NIH HHS R01 MH068212
6 · The paper itself

Abstract

Cells possess complex growth factor networks that play vital roles in regulating fundamental life processes. Such protein factors exert their action by binding to cognate cell specific receptors resulting in regulation of cell division, differentiation, chemotaxis or apoptosis. Engagement of receptors by their respective ligands results in activation of sequential protein phosphorylation cascades, culminating downstream into activation of gene transcription. These factors are expressed ubiquitously under a variety of conditions by normal as well as transformed cells, thereby underpinning their function in autocrine and paracrine stimulation of cells under several physiological and pathological conditions. Despite major advances in our understanding of growth factors, their paradoxical roles in normal cellular homeostasis and pathologies underpin the need to examine their roles in disease and health. The goal of this special issue is to present emerging trends in the roles that growth factors play in inflammatory disease processes that include cardiovascular, cancer, stroke and neurodegenerative processes associated with aging, viral infection and substance abuse with the ultimate aim to pave the way for future therapeutic breakthroughs.

Indexed as

AnimalsHumansInflammationIntercellular Signaling Peptides and ProteinsNeurodegenerative DiseasesSignal TransductionIntercellular Signaling Peptides and Proteins

Identifiers

PMID24610034
PMCPMC4049333
OpenAlexW2065989066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.